Funding Opportunities

Second call open - AECC Talent 

The postdoctoral fellowship programme AECC Talent launched by the Scientific Foundation of the Spanish Association Against Cancer (FCAECC), is a unique opportunity for talented postdoctoral cancer researchers across the globe to carry out their research projects in one of the selected host cancer research centres in Spain co-funded by the European Union through the Marie Skłodowska-Curie Actions COFUND programme of the European Commission

Host research centres participating in the programme are endorsed by FCAECC as excellent in cancer research by means of a rigorous assessment process that guarantees their quality, impact, and leadership in cancer research at national and international level. Fellows will have a wide choice of entities and multidisciplinary teams in which to carry out the project of their interest, following a bottom-up approach. 

In addition, fellows will be able to carry out international, intersectoral and interdisciplinary secondments, that may range from one month to one year, through which they will boost their networking opportunities and expand their interdisciplinarity.  Moreover, AECC TALENT will provide a comprehensive training programme to its fellows with yearly sessions that will range from specific courses and seminars on research skills to non-research oriented transferable skills, innovation and leadership courses provided by experts in the corresponding fields. 

Detailed information about the programme and application process can be found on AECC Talent website. 

APPLICATIONS: September 26th – November 21st 2024 
Contact: fundacion.cientifica@contraelcancer.es 

Web: https://aecctalent.com/  

Very pleased to announce a grant opportunity to encourage academic researchers to advance their preclinical discoveries into clinical studies to tackle pancreatic cancer. This is open to anyone, anywhere in the world.

We are looking for interventions with sound preclinical data in pancreatic ductal adenocarcinoma that is mature enough to be taken forward into a clinical trial. The aim of the grant is to aid investigators in developing and transforming their preclinical results into a high-quality clinical trial by providing seed funding to develop the protocol.

Deadline for submission is Tuesday 1 October 2024, 23:59 CET

More information available here: https://www.anticancerfund.org/RFA

WCRF International, in partnership with American Institute for Cancer Research, World Cancer Research Fund and Wereld Kanker Onderzoek Fonds has launched the INSPIRE Research Challenge 2024 call. This will prioritise innovative, bold, and creative proposals with the potential to catalyse rapid and impactful advances in cancer prevention, treatment and survivorship.  

Eligibility:

• The programme is open to early career individuals – defined as not less than 2 years, but not more than 6 years post-doctoral degree (PhD or MD research) from anywhere in the world
• Applicants must be employed on a research contract within a department at a research institution affiliated with a university or medical school.
• Proposed projects must have direct relevance to cancer prevention, treatment or survivorship and may address any or all stages of the cancer journey.
• Proposals should address modifiable factors including both lifestyle – such as diet, nutrition, physical activity – and environmental factors – such as pollution/contaminants and pathogens.
• Particular priority will be given to novel exposures including stress, sleep and host factors such as immune function.

Deadline: Friday 8th March

For further details visit:

• https://www.wcrf.org/research-we-fund/grant-programmes/inspire-research-challenge/  

This grants program, focused initially on Uganda and Kenya, will serve as a pilot initiative to advancing clinical cancer research for rapid impact on patient outcomes in sub-Saharan Africa; and to enhancing capacities to empower applicants from these countries to effectively compete as leading investigators for global research opportunities in the future. Lessons learned from this pilot will serve as a basis to expand this program in subsequent years to encompass additional sub-Saharan African countries. 

Supported Research Approaches, and Permissible Technical Foci:

Areas of cancer intervention that will be supported under this program include early detection and diagnosis, treatment, delivery of care, and palliative care. 

• Applications focused on breast, colorectal, esophageal, or hematological cancers are strongly encouraged. Applications focused on cancers largely supported under global infectious disease investments (such as cervical or Kaposi Sarcoma) should NOT be submitted. 

• RTFCCR is particularly interested in research that can lead to better patient outcomes in the near-term future, including quality of life; with an emphasis on outcomes identified in partnership with patients. 

• Implementation research, as well as clinical trials, both bio-medical and behavioral, will be supported under this RFP.  Proposals for basic and/or translational research are NOT invited and will NOT be reviewed.  

RTFCCR has a particular interest in drug-repurposing, therapy de-escalation, and palliative care, as well as application of technology to expand capacity in-country for detection and/or treatment. Regardless of the specific focus or approach, applicants must include Patients as Partners in their efforts to be eligible for funding under this RFP.

Deadline:

• Stage I: Needs Assessment and Planning Grants - 1 December, 2023

For further details please visit http://www.risingtide-foundation.org/clinical-cancer-research-advancing-cancer-research-in-sub-saharan-africa/

The MSCA COFUND postdoctoral fellowship programme AECC Talent launched by the Scientific Foundation of the Spanish Association Against Cancer (FCAECC), is a unique opportunity for talented postdoctoral cancer researchers across the globe to carry out their research projects in one of the selected host cancer research centres in Spain. 

Host research centres participating in the programme are endorsed by FCAECC as excellent in cancer research by means of a rigorous assessment process that guarantees their quality, impact, and leadership in cancer research at national and international level. Fellows will have a wide choice of entities and multidisciplinary teams in which to carry out the project of their interest, following a bottom-up approach. 

In addition, fellows will be able to carry out international, intersectoral and interdisciplinary secondments, that may range from one month to one year, through which they will boost their networking opportunities and expand their interdisciplinarity.  Moreover, AECC TALENT will provide a comprehensive training programme to its fellows with yearly sessions that will range from specific courses and seminars on research skills to non-research oriented transferable skills, innovation and leadership courses provided by experts in the corresponding fields. 

Detailed information about the programme and application process can be found on AECC Talent website. 

APPLICATIONS: September 28th – November 23rd 2023 
Contact: fundacion.cientifica@contraelcancer.es 

Web: https://aecctalent.com/  

Dreaming of a career in cancerr esearch in Italy? Apply for AIRC's start-up grants. Find out more at https://www.direzionescientifica.airc.it/funding-for-research/individual-grants

Deadline 3 March 2023

For further details visit www.direzionescientifica.airc.it  or contact airc at: direzione-scientifica@airc.it

World Cancer Research Fund International (WCRF International) is now accepting grant applications for research on the role of diet, weight, nutrition and physical activity on cancer prevention and cancer survival, as part of its Regular Grant Programme 2022/2023 cycle.

Visit https://www.wcrf.org/int/research-we-fund/grant-programmes/apply-research-grant for more information.

Applications are accepted from principal investigators based at institutions in any country outside the Americas (North America, Central America and the Caribbean, and South America). Applications from the Americas can be submitted to the American Institute for Cancer Research at www.aicr.org. Applications from an eligible principal investigator with co-applicants/collaborators from anywhere in the world are welcome.

Only applications that meet our eligibility criteria and adhere to our research principles and themes will be considered. Please note the grant programme’s scope has been updated: applicants are encouraged to read the application guidelines carefully before applying (link to guidelines PDF: https://www.wcrf.org/wp-content/uploads/2022/09/WCRF_Grants_Guidelines_2022.pdf)

The deadline for applications is 7th November 2022.

Any questions can be emailed to research@wcrf.org, but please refer to our FAQs and guidelines document in the first instance.

Purpose of Grant: To support rigorous scientific oncology nursing research. Research projects may include investigator-initiated research, pilot or feasibility studies, supplements to current funded projects, or developing a new aspect of a program of research. Funding preference is given to projects that involve nurses in the design and conduct of the research activity and that promote theoretically based oncology practice. Competitive applications will address a topic(s) in the ONS Research Agenda. See "Research Agenda of the Oncology Nursing Society: 2019-2022," published in the Oncology Nursing Forum, November 2019, Volume 46, No. 6.

The following three (3) key areas in need of oncology nursing research articulated in the ONS Research Agenda are:
• Symptom Science 
  ◦ In Immunotherapy and Emerging Therapies in Precision Health  
  ◦ In Precision Health and Biosignature
• Health Disparities
• Palliative and Psychosocial Oncology Care

Additional resources and updates related to the ONS Research Agenda are located here: “Update to the 2019-2022 ONS Research Agenda: Rapid Review to Address Structural Racism and Health Inequities,” published in the Oncology Nursing Forum, November 2021, Volume 48, No. 6; and, “The Oncology Nursing Society Rapid Review and Research Priorities for Cancer Care in the Context of Covid-19,” published in the Oncology Nursing Forum, March 2021, Volume 48, No. 2.

Funding Amounts:
$50,000 and $100,000

Duration of project and funding:
2 years

Letter of Intent Due Date:
May 8th, 2022

Visit the Oncology Nursing Foundation Research Grants page for more eligibility information and to apply

Please share within your networks. Deadline for submission of letters of intent is 1 May 2022.

This Request For Application (RFA) seeks to increase clinical trial activities in patients diagnosed with brain metastases. We are looking for innovative approaches that can improve survival rate in this specific patient population. The focus is on clinical trials assessing interventions that can increase survival or induce durable responses.

We welcome applications from all over the world and do not have geographical restrictions.

As ACF seeks proposals in line with its vision and mission, the proposed intervention must be commercially neglected (as defined in detail in the eligibility criteria). 

You will find more information about this RFA here: https://www.anticancerfund.org/en/clinical-trials-brain-metastases

Gauthier

World Cancer Research Fund International (WCRF International) is now accepting grant applications for research on the links between diet, nutrition (including body composition) and physical activity and cancer, as part of its Regular Grant Programme 2021/2022 cycle.

Eligibility: Applicants can be based in any country outside the Americas. More information on the eligibility and the scientific scope of the grant call is available from https://www.wcrf.org/int/research-we-fund/grant-programmes/apply-research-grant. (Applications from the Americas can be submitted to the American Institute for Cancer Research at www.aicr.org). Applications from an eligible principal investigator with co-applicants/collaborators from anywhere in the world are welcome.

Please ensure you read the ‘Guidelines for research grant applicants & award recipients’ carefully before applying.

The deadline for applications is 16th November 2021.

The Anticancer Fund and the Rising Tide Foundation for Clinical Cancer Research are pleased to announce a joint Request for Application (RFA) about pancreatic and biliary tract cancers.

We are seeking to support clinical trials testing novel and unique strategies in the treatment of patients diagnosed with pancreatic ductal adenocarcinomas (PDAC) and/or biliary tract cancer (BTC). The proposal needs to have the potential to have a high impact (e.g. improve cure rate or survival) on the treatment of these cancers.

We foresee a total budget of 3 million US dollars and we anticipate supporting up to 1-3 trials with this budget.

All details of this opportunity are available here: https://www.anticancerfund.org/en/request-application

Thanks in advance for spreading the news!

Gauthier

NCI is pleased to announce the publication of a new NCI funding opportunity announcement (FOA): Cancer Prevention, Detection, Diagnosis, and Treatment Technologies for Global Health (U01 Clinical Trial Optional).

NCI will host an informational webinar for potential applicants on Friday, March 12th from 9:00 AM to 10:30 AM Eastern Time. NCI program staff will present on the scope and focus of the program and take questions from interested potential applicants.

Open Date: May 02, 2021

Expiration Date: June 03, 2021

This new FOA supports the development of cancer-relevant technologies suitable for use in low- and middle-income countries (LMICs). Specifically, the FOA solicits applications for projects to adapt, apply, and validate existing or emerging technologies into a new generation of user-friendly, low-cost technologies for preventing, detecting, diagnosing, and/or treating cancers in people living in LMICs.

Applicants should have a working assay or device prototype (not necessarily already capable of cancer applications). The U01 project includes studies to both adapt this technology as well as demonstrate technical functionality and clinical performance for use of the device or assay in specific LMIC settings by meeting objective performance milestones followed by improvements and validations of the technologies in the LMIC settings. Projects proposed in response to this FOA will require multidisciplinary efforts to succeed; therefore, all applicant teams must include expertise in engineering/assay/treatment development, oncology, global healthcare delivery, and business development. Investigators responding to this FOA must consider affordability and cost-effectiveness as well as usability at the point-of-need as part of their design criteria.

This funding opportunity is part of a broader NCI-sponsored Affordable Cancer Technologies (ACTs) Program.

Visit the ACTs webpage at for additional program contacts, answers to frequently asked questions, and information on previously funded ACTs awards.